Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 5 Nausea 5 Neoplasms 4 Hematologic Neoplasms 4 Anorexia 3 Multiple Myeloma 2 Breast Neoplasms 2 Testicular Neoplasms 1 Solid Tumor Patients Receiving High Emetic Risk Multi-day Chemotherapy 1 Prosthesis Failure 1 Opioid-Related Disorders 1 Nutrition Disorders 1 Neoplasms, Plasma Cell 1 Gynecologic Cancer 1 Cachexia 1 Advanced Cancer 1

Interventions

Megestrol Acetate 5 anamorelin 1 Standard of Care 1 Radiotherapy 1 Olanzapine 1 Melatonin 1 Infliximab 1 Ibuprofen 1 Etanercept 1 Eicosapentaenoic Acid 1 Docetaxel 1 Dietary Supplements 1 Cyproheptadine 1 Creatine 1 Counseling 1 Caseins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Cachexia × Olanzapine × Clear all

NCT06517199 2024-07-24

Olanzapine for Cancer Related Anorexia-cachexia Syndrome

Mahidol University

Phase 3 Recruiting

Anorexia, Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡